Boston Scientific
879 hedge funds and large institutions have $56.6B invested in Boston Scientific in 2021 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 345 increasing their positions, 285 reducing their positions, and 62 closing their positions.
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
29% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 62
21% more repeat investments, than reductions
Existing positions increased: 345 | Existing positions reduced: 285
1% more funds holding
Funds holding: 870 → 879 (+9)
2% more capital invested
Capital invested by funds: $55.4B → $56.6B (+$1.14B)
0.33% more ownership
Funds ownership: 91.17% → 91.5% (+0.33%)
38% less call options, than puts
Call options by funds: $305M | Put options by funds: $491M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$202M |
| 2 |
Citigroup
New York
|
+$194M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$190M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$153M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$116M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$285M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$227M |
| 3 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$138M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$124M |
| 5 |
BG
Bollard Group
Boston,
Massachusetts
|
-$116M |
BSX Hedge Fund Activity: Q3 2021 in Review
879 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2021, worth a combined $56.6B — up 2.1% from $55.4B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new BSX positions and 62 closed out — a net gain of 18 holders — while 345 added to existing stakes and 285 trimmed.
The largest buyer was BlackRock, adding an estimated $202M. The largest seller was Viking Global Investors, cutting an estimated $285M.
- 879 institutional investors held Boston Scientific (BSX) as of Q3 2021, up from 870 in Q2 2021.
- Funds reported $56.6B of Boston Scientific stock for Q3 2021, up 2.1% quarter-over-quarter.
- 80 funds opened new Boston Scientific positions in Q3 2021 and 62 closed out, a net change of +18 holders.
- The largest Boston Scientific buyer in Q3 2021 was BlackRock, an estimated $202M added.
- The largest Boston Scientific seller in Q3 2021 was Viking Global Investors, an estimated $285M sold.
Based on aggregated 13F filings for Q3 2021.